Salvage liver transplantation or repeat hepatectomy for recurrent hepatocellular carcinoma: An intent-to-treat analysis
- PMID: 28945955
- DOI: 10.1002/lt.24952
Salvage liver transplantation or repeat hepatectomy for recurrent hepatocellular carcinoma: An intent-to-treat analysis
Abstract
The salvage liver transplantation (LT) strategy was conceived for initially resectable and transplantable hepatocellular carcinoma (HCC) to obviate upfront transplantation, with salvage LT in the case of recurrence. The longterm outcomes of a second resection for recurrent HCC have improved. The aim of this study was to perform an intention-to-treat analysis of overall survival (OS) comparing these 2 strategies for initially resectable and transplantable recurrent HCC. From 1994 to 2011, 391 patients with HCC who underwent salvage LT (n = 77) or a second resection (n = 314) were analyzed. Of 77 patients in the salvage LT group, 21 presented with resectable and transplantable recurrent HCC and 18 underwent transplantation. Of 314 patients in the second resection group, 81 presented with resectable and transplantable recurrent HCC and 81 underwent a second resection. The 5-year intention-to-treat OS rates, calculated from the time of primary hepatectomy, were comparable between the 2 strategies (72% for salvage transplantation versus 77% for second resection; P = 0.57). In patients who completed the salvage LT or second resection procedure, the 5-year OS rates, calculated from the time of the second surgery, were comparable between the 2 strategies (71% versus 71%; P = 0.99). The 5-year disease-free survival (DFS) rates were 72% following transplantation and 18% following the second resection (P < 0.001). Similar results were observed after propensity score matching. In conclusion, although the 5-year OS rates were similar in the salvage LT and second resection groups, the salvage LT strategy still achieves better DFS. Second resection for recurrent HCC might be considered to be the best alternative option to LT in the current organ shortage. Liver Transplantation 23 1553-1563 2017 AASLD.
© 2017 by the American Association for the Study of Liver Diseases.
Similar articles
-
Salvage Versus Primary Liver Transplantation for Early Hepatocellular Carcinoma: Do Both Strategies Yield Similar Outcomes?Ann Surg. 2016 Jul;264(1):155-63. doi: 10.1097/SLA.0000000000001442. Ann Surg. 2016. PMID: 26649581
-
Liver transplantation versus liver resection for hepatocellular carcinoma in intention to treat: An attempt to perform an ideal meta-analysis.Liver Transpl. 2017 Jun;23(6):836-844. doi: 10.1002/lt.24758. Liver Transpl. 2017. PMID: 28295992 Review.
-
Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?Ann Surg. 2003 Oct;238(4):508-18; discussion 518-9. doi: 10.1097/01.sla.0000090449.87109.44. Ann Surg. 2003. PMID: 14530722 Free PMC article.
-
Curative salvage liver transplantation in patients with cirrhosis and hepatocellular carcinoma: An intention-to-treat analysis.Hepatology. 2018 Jan;67(1):204-215. doi: 10.1002/hep.29468. Epub 2017 Nov 15. Hepatology. 2018. PMID: 28806477
-
Comparison Between Salvage Liver Transplantation and Repeat Liver Resection for Recurrent Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.Transplant Proc. 2019 Mar;51(2):433-436. doi: 10.1016/j.transproceed.2019.01.072. Epub 2019 Jan 29. Transplant Proc. 2019. PMID: 30879559
Cited by
-
Transplant Oncology: An Emerging Discipline of Cancer Treatment.Cancers (Basel). 2023 Nov 9;15(22):5337. doi: 10.3390/cancers15225337. Cancers (Basel). 2023. PMID: 38001597 Free PMC article. Review.
-
[METTL14 as a predictor of postoperative survival outcomes of patients with hepatocellular carcinoma].Nan Fang Yi Ke Da Xue Xue Bao. 2020 Apr 30;40(4):567-572. doi: 10.12122/j.issn.1673-4254.2020.04.19. Nan Fang Yi Ke Da Xue Xue Bao. 2020. PMID: 32895140 Free PMC article. Chinese.
-
Safety of laparoscopic hepatectomy in patients with hepatocellular carcinoma and portal hypertension: interim analysis of an open prospective study.Surg Endosc. 2019 Mar;33(3):811-820. doi: 10.1007/s00464-018-6347-1. Epub 2018 Jul 12. Surg Endosc. 2019. PMID: 30003350 Clinical Trial.
-
Surgical treatment for recurrent hepatocellular carcinoma: Current status and challenges.World J Gastrointest Surg. 2023 Apr 27;15(4):544-552. doi: 10.4240/wjgs.v15.i4.544. World J Gastrointest Surg. 2023. PMID: 37206072 Free PMC article. Review.
-
A nomogram predicting the recurrence of hepatocellular carcinoma in patients after laparoscopic hepatectomy.Cancer Commun (Lond). 2019 Oct 11;39(1):55. doi: 10.1186/s40880-019-0404-6. Cancer Commun (Lond). 2019. PMID: 31601270 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical